[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"HAII corp.ltd\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100563361",false,"NCT06615167","Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders","A Single-blind (Data Analyst 1), Single-arm Design, Prospective, Multi-center Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders According to DSM-5","Inclusion Criteria:\n\n* Participants must be between 55 and 85 years old (both men and women).\n* Participants must be able to understand and voluntarily agree to the purpose, content, and procedures of the clinical trial.\n\nExclusion Criteria:\n\n* Participants with no literacy or illiteracy.\n* Participants with an intellectual disability.\n* Participants with presenting active psychiatric symptoms.\n* Participants who have difficulty ALZGUARD application\n* Participants who are unable to use a smartphone, unless they can use it with assistant.\n* Participants with a history of suicidal ideation or suicidal complusion in the last 6 months.\n* Other conditions as deemed inappropriate for study participant by the Principal Investigator(PI).","ALL","55 Years","85 Years",{"count":19,"type":20},122,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to evalute the efficacy of ALZGUARD, a smartphone-based digital therapeutic(DTx), in comparison to diagnosis by medical doctors, as weel as to assess the safety of the application.",[26,27],"Dementia","Major Neurocognitive Disorder","RECRUITING","2024-09-25",{"date":31,"type":32},"2024-09-26","ACTUAL",{"date":34,"type":32},"2024-09-12",{"date":36,"type":20},"2025-04-30",{"name":38,"class":39},"HAII corp.ltd","INDUSTRY",3,""]